Bank of New York Mellon’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-86,496
| Closed | -$1.87M | – | 4474 |
|
|
2022
Q4 | $1.87M | Buy |
86,496
+774
| +0.9% | +$16.4K | ﹤0.01% | 2890 |
|
|
2022
Q3 | $1.66M | Sell |
85,722
-1,402
| -2% | -$29K | ﹤0.01% | 2951 |
|
|
2022
Q2 | $1.73M | Sell |
87,124
-9,444
| -10% | -$249K | ﹤0.01% | 2914 |
|
|
2022
Q1 | $2.88M | Buy |
96,568
+12,600
| +15% | +$369K | ﹤0.01% | 2728 |
|
|
2021
Q4 | $1.96M | Sell |
83,968
-388
| -0.5% | -$10.3K | ﹤0.01% | 3012 |
|
|
2021
Q3 | $2.63M | Buy |
84,356
+4,198
| +5% | +$130K | ﹤0.01% | 2835 |
|
|
2021
Q2 | $2.82M | Sell |
80,158
-12,764
| -14% | -$415K | ﹤0.01% | 2789 |
|
|
2021
Q1 | $3.28M | Buy |
92,922
+12,293
| +15% | +$454K | ﹤0.01% | 2649 |
|
|
2020
Q4 | $3.02M | Buy |
80,629
+27,617
| +52% | +$1M | ﹤0.01% | 2603 |
|
|
2020
Q3 | $1.77M | Sell |
53,012
-1,158
| -2% | -$33.7K | ﹤0.01% | 2744 |
|
|
2020
Q2 | $1.44M | Buy |
54,170
+9,426
| +21% | +$222K | ﹤0.01% | 2883 |
|
|
2020
Q1 | $733K | Buy |
44,744
+8,429
| +23% | +$185K | ﹤0.01% | 3175 |
|
|
2019
Q4 | $923K | Buy |
36,315
+2,750
| +8% | +$55K | ﹤0.01% | 3287 |
|
|
2019
Q3 | $671K | Buy |
33,565
+1,473
| +5% | +$38.1K | ﹤0.01% | 3385 |
|
|
2019
Q2 | $1.03M | Sell |
32,092
-5,796
| -15% | -$194K | ﹤0.01% | 3183 |
|
|
2019
Q1 | $1.22M | Buy |
37,888
+336
| +0.9% | +$9.05K | ﹤0.01% | 3041 |
|
|
2018
Q4 | $921K | Buy |
37,552
+2,529
| +7% | +$66.8K | ﹤0.01% | 3155 |
|
|
2018
Q3 | $1.15M | Buy |
35,023
+2,760
| +9% | +$90.3K | ﹤0.01% | 3185 |
|
|
2018
Q2 | $1.15M | Buy |
32,263
+21,685
| +205% | +$702K | ﹤0.01% | 3179 |
|
|
2018
Q1 | $345K | Buy |
10,578
+2,140
| +25% | +$72.1K | ﹤0.01% | 3749 |
|
|
2017
Q4 | $216K | Buy |
+8,438
| New | +$214K | ﹤0.01% | 3921 |
|
|
2015
Q3 | – | Sell |
-479
| Closed | -$15K | – | 4414 |
|
|
2015
Q2 | $15K | Buy |
479
+124
| +35% | +$4.17K | ﹤0.01% | 4240 |
|
|
2015
Q1 | $12K | Sell |
355
-61
| -15% | -$2.57K | ﹤0.01% | 4210 |
|
|
2014
Q4 | $16K | Buy |
416
+9
| +2% | +$395 | ﹤0.01% | 4216 |
|
|
2014
Q3 | $20K | Hold |
407
| – | – | ﹤0.01% | 4203 |
|
|
2014
Q2 | $26K | Buy |
407
+2
| +0.5% | +$139 | ﹤0.01% | 4120 |
|
|
2014
Q1 | $33K | Hold |
405
| – | – | ﹤0.01% | 4121 |
|
|
2013
Q4 | $28K | Hold |
405
| – | – | ﹤0.01% | 4160 |
|
|
2013
Q3 | $38K | Hold |
405
| – | – | ﹤0.01% | 4074 |
|
|
2013
Q2 | $51K | Buy |
+405
| New | +$42.1K | ﹤0.01% | 4036 |
|
Other funds holding ALBO
Bank of New York Mellon's ALBO Position: Q1 2023 in Review
Bank of New York Mellon sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 86,496 shares — an estimated $1.87M sold.
Bank of New York Mellon first reported a position in ALBO in Q2 2013 and held it in 30 quarters. The position peaked at $3.28M in Q1 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Bank of New York Mellon reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Bank of New York Mellon sold 86,496 Albireo Pharma Inc shares in Q1 2023, an estimated $1.87M.
- Bank of New York Mellon first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 30 quarters.
- Bank of New York Mellon's Albireo Pharma Inc position peaked at $3.28M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.